Participating in the MiDe Study
By joining the MiDe Study, you can make a difference by helping us to better understand how ovarian cancer develops in high-risk people. Please join our effort to better understand this rare cancer.
Eligibility
Adults over the age of 18 with at least one ovary intact and no personal history of ovarian cancer are invited to join the MiDe Study. If you are unsure if you may be eligible, please contact the study team. Additionally, eligible adults may:
- Have a genetic variant(s) linked to ovarian cancer on genetic testing, such as BRCA1, BRCA2, BRIP1, RAD51C, RAD51D, PMS2, MLH1, MSH2, MSH6, PALB2, or EPCAM
- Have a blood relative who carries a genetic variant found on genetic testing
- Have a family history of cancer, such as breast, ovarian, or gastrointestinal (GI) cancer(s)
Participating in the MiDe Study means that you’ll:
- Review and sign a consent form
- Complete a family history questionnaire and provide updates on your personal and family history periodically throughout your time in the study
- Allow us to access your medical records for information that may be important to your participation in the study
- Provide up to 4 tubes of blood every 6 months for up to 5 years
- Allow us to collect some of your biopsy or surgery tissue samples for research, if possible